Erratum to

Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: Results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients) (American Journal of Cardiovascular Drugs (2014) 14, (137-145) DOI: 10.1007/s40256-014-0067-2)

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)239
Number of pages1
JournalAmerican Journal of Cardiovascular Drugs
Volume14
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Indapamide
Perindopril
Cardiovascular Agents
Amlodipine
Antihypertensive Agents

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

@article{6fe9f15e0bf141289ecca2375b29ae79,
title = "Erratum to: Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: Results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients) (American Journal of Cardiovascular Drugs (2014) 14, (137-145) DOI: 10.1007/s40256-014-0067-2)",
author = "K. T{\'o}th",
year = "2014",
doi = "10.1007/s40256-014-0076-1",
language = "English",
volume = "14",
pages = "239",
journal = "American Journal of Cardiovascular Drugs",
issn = "1175-3277",
publisher = "Adis International Ltd",
number = "3",

}

TY - JOUR

T1 - Erratum to

T2 - Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: Results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients) (American Journal of Cardiovascular Drugs (2014) 14, (137-145) DOI: 10.1007/s40256-014-0067-2)

AU - Tóth, K.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904250444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904250444&partnerID=8YFLogxK

U2 - 10.1007/s40256-014-0076-1

DO - 10.1007/s40256-014-0076-1

M3 - Article

VL - 14

SP - 239

JO - American Journal of Cardiovascular Drugs

JF - American Journal of Cardiovascular Drugs

SN - 1175-3277

IS - 3

ER -